Mozhgan Sadat Ghaemmohamadi1, Meysam Behzadifar2, Ahmad Ghashghaee1, Nasrin Mousavinejad3, Faezeh Ebadi1, Sahar Sadat Saeedi Shahri1, Hesam Seyedin4, Masoud Behzadifar5, Nicola Luigi Bragazzi6. 1. Student Research Committee, Faculty of Health Management and Information Sciences Branch, Iran University of Medical Sciences, Tehran, Iran. 2. Health Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran. 3. Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. 4. Department of Health Services Management, School of Health Management and Information Sciences, Iran University of Medical Sciences, Tehran, Iran. 5. Social Determinants of Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. Electronic address: masoudbehzadifar@gmail.com. 6. School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Abstract
BACKGROUND: In both developed and developing countries, cardiovascular disease is on the rise, representing nowadays one of the main challenges for the health systems worldwide. This increase generates relevant costs. The aim of this study was to conduct a systematic and meta-analytical review of the prevalence of depression in cardiovascular patients in Iran. METHODS: Articles written in English and Persian were searched from January 2000 to July 2017 in different scholarly databases. RESULTS: 12 studies were retained and included in the current meta-analysis. Selected studies were published between 2008 and 2016. The number of patients participating in these studies was 9292. Based on the random-effects model, the prevalence of depression in cardiovascular patients in Iran was 47% [95% confidence interval or CI 38-56], I2=98.2% with P = 0.000. The relative risk (RR) of depression in cardiovascular patients yielded a value of 1.30 [95%CI 1.05-1.62] with P < 0.001. Women are more at risk for depression than men. CONCLUSION: The current meta-analysis estimated the prevalence of depression among cardiovascular patients in Iran. The prevalence found computed by the present study is higher than the figures found in developed countries. Depression with cardiovascular disease causes many problems for these patients, and early diagnosis and treatment significantly helps in improving quality of life, as well as saving costs and resources.
BACKGROUND: In both developed and developing countries, cardiovascular disease is on the rise, representing nowadays one of the main challenges for the health systems worldwide. This increase generates relevant costs. The aim of this study was to conduct a systematic and meta-analytical review of the prevalence of depression in cardiovascularpatients in Iran. METHODS: Articles written in English and Persian were searched from January 2000 to July 2017 in different scholarly databases. RESULTS: 12 studies were retained and included in the current meta-analysis. Selected studies were published between 2008 and 2016. The number of patients participating in these studies was 9292. Based on the random-effects model, the prevalence of depression in cardiovascularpatients in Iran was 47% [95% confidence interval or CI 38-56], I2=98.2% with P = 0.000. The relative risk (RR) of depression in cardiovascularpatients yielded a value of 1.30 [95%CI 1.05-1.62] with P < 0.001. Women are more at risk for depression than men. CONCLUSION: The current meta-analysis estimated the prevalence of depression among cardiovascularpatients in Iran. The prevalence found computed by the present study is higher than the figures found in developed countries. Depression with cardiovascular disease causes many problems for these patients, and early diagnosis and treatment significantly helps in improving quality of life, as well as saving costs and resources.
Authors: Ibrahim Abdollahpour; Zahra Golestannejad; Yahya Salimi; Saharnaz Nedjat; Isabel Aguilar-Palacioc; Mohammad Ali Mansournia; Maximilian de Courten Journal: Tob Use Insights Date: 2022-05-15